nanotech investing Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process
nanotech investing Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process
nanotech investing Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process
nanotech investing Universal Ibogaine advises further on application for Management Cease Trade Order
Equity Metals Reports Assays from 2026 Validation Drilling on the No. 3 Vein and Active Q4 Exploration Initiatives, Silver Queen Project, BC
